|
|
|
|
Chronic Myelogenous Leukemia
Time In - Katie Knudson Dec 20, 2005
U.S. National Soccer Players, By the time they had Katie's fever under control and were ready to send her home, they also had a diagnosis - Chronic Myelogenous Leukemia (CML), a type of ...
Researchers Closer to Understanding How One Mutation Causes Three ... Dec 19, 2005
Howard Hughes Medical Institute, ...“Although relatively rare individually, together these disorders are about five times more common than chronic myelogenous leukemia.�. ...
Silent Night, holy night, all is calm, all is bright… Dec 20, 2005
HoweStreet.com, ...well. Chronic myelogenous leukemia (CML) may benefit from the root of a common ornamental plant known as coleus forskohili. The ...
Backyard Garden May Yield Leukemia Treatment Dec 9, 2005
Science Daily (press release) Scientists here have identified a new pathway in the progression of chronic myelogenous leukemia (CML). They also discovered that ...
Cell Genesys Reports Positive Results From Phase 2 Trial of GVAX(R ... Dec 12, 2005
PR Newswire (press release), ...(Nasdaq: CEGE) today reported encouraging clinical data from a Phase 2 trial of GVAX(R) vaccine for chronic myelogenous leukemia (CML). ...
Dacogen(TM) (Decitabine) Injection Data Presented at American ... Dec 12, 2005
Genetic Engineering News, Data from a phase 2 study of Dacogen injection in combination with imatinib in patients with chronic myelogenous leukemia (CML) were presented in a poster ...
Dacogen(TM) (Decitabine) Injection Complete Response Accepted for ... Dec 15, 2005
Genetic Engineering News, ...currently being evaluated in a broad clinical development program in patients with MDS, acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and ...
Cell Genesys says Phase 2 trail for leukemia vaccine positive Dec 12, 2005
Reuters ...(CEGE.O: Quote, Profile, Research) on Monday said results from its Phase 2 trial of a vaccine for chronic myelogenous leukemia, GVAX, is encouraging. ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 11, 2005
PR Newswire (press release), ...(1) Abstract 4839, entitled "Subcutaneous (SC) Homoharringtonine (HHT) for Patients with Chronic Myelogenous Leukemia (CML) in Chronic Phase after Imatinib ...
Common garden plant may hold cure for leukemia Dec 12, 2005
News-Medical.net, Scientists in the US believe they have identified a new pathway in the progression of chronic myelogenous leukemia (CML). They have ...
Dacogen(TM) (Decitabine) Injection Data Presented at American ... Dec 12, 2005
PR Newswire (press release), Imatinib in CML Patients Data from a phase 2 study of Dacogen injection in combination with imatinib in patients with chronic myelogenous leukemia (CML) were ...
SGX Pharmaceuticals Presenting Data at American Society of ... Dec 13, 2005
Yahoo! News (press release) The clinical success of Gleevec has demonstrated that BCR-ABL kinase inhibitors can provide effective treatment of Chronic Myelogenous Leukemia (CML). ...
Cell Genesys Posts Positive Study Data Dec 12, 2005
MSN Money All patients in the nine-week study had chronic myelogenous leukemia whose disease had persisted despite more than one year on another drug, Novartis AG's ...
Philip J. Fialkow, MD and Helen Fialkow found dead in Nepal on Nov ... Nov 30, 2005
uwnews.org, ...proof that a common lympho-hematopoietic stem cell exists in humans, and the first evidence for the multistep pathogenesis of chronic myelogenous leukemia. ...
AstraZeneca's Casodex may get boost Dec 8, 2005
Science Daily (press release) BMS' dasatinib expected to rival Gleevec (November 21, 2005) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib ...
Kosan Initiates Phase II Clinical Trial of KOS-953 in Combination ... Dec 8, 2005
PR Newswire (press release), FDA) and the European Medicines Agency (EMEA) for the treatment of multiple myeloma as well as another hematologic cancer, chronic myelogenous leukemia. ...
CML Vaccine Gives Uneven Results in Control of Residual Disease Dec 13, 2005
Cancerpage.com, NEW YORK DEC 12, 2005 (Reuters Health) - A vaccine against chronic myelogenous leukemia (CML) has resulted in a molecular response, to varying degrees, in most ...
Trials help patients get new treatments Dec 11, 2005
The Jackson Citizen-Patriot, ...patient who comes immediately to Clark's mind is Beth Hagaman of Leoni Township, who was diagnosed a decade ago with chronic myelogenous leukemia (see article ...
Discoveries Reveal Gene Mutation That Causes Blood Disorders Dec 11, 2005
PR Newswire (press release), Abnormal regulation or function of tyrosine kinases have been implicated in many cancers, including chronic myelogenous leukemia (CML), the treatment of which ...
It's a sad journey along a fast road to see our parents Dec 11, 2005
Richmond Times Dispatch, ...offered. My father had chronic myelogenous leukemia, and he was experiencing a blast crisis, the final stages of the disease. Then ...
BMS' dasatinib expected to rival Gleevec Nov 21, 2005
Science Daily (press release) 21 (UPI) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib, which is currently in phase 2 trials, could be as ...
Health calendar and support groups Nov 27, 2005
OCRegister, ...(714) 633-6858. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. Hoag Memorial Hospital Presbyterian, One Hoag Drive, Cancer Center, Newport Beach. ...
Writer has strange encounter of the meaningful kind Dec 4, 2005
Richmond Times Dispatch, Of course, I knew the answer to that one. Leukemia. Chronic myelogenous leukemia. I think about my father often, but not in ways you might suspect. ...
A Thanksgiving worth cheering for Nov 23, 2005
Columbia Falls Hungry Horse News, And that's saying something. Two years ago Dunlap was diagnosed with chronic myelogenous leukemia. She was 15 and a sophomore at the time. ...
BMS` dasatinib expected to rival Gleevec Nov 21, 2005
Monsters and Critics.com, WASHINGTON, DC, United States (UPI) -- An analyst firm predicts Bristol Myers Squibb`s chronic myelogenous leukemia drug dasatinib, which is currently in phase ...
Nanoparticle encapsulation improves bioavailability of leukemia ... 09 Oct 2006
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia. ... News-Medical.net,
NCCN Updates Chronic Myelogenous Leukemia Guidelines Oct 3, 2006
Cancer Network (NCCN) is proud to announce several new updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Chronic Myelogenous Leukemia (CML). ... Genetic Engineering News (press release),
Three Molecular Triggers Threaten Leukemia Patients: Multidrug ... Oct 8, 2006
One of the great successes of cancer treatment has been development of targeted therapy for chronic myelogenous leukemia (CML). ... Medical News Today (press release),
Cancer drug may decrease heart function, company advises Oct 2, 2006
...professionals. Gleevec was designed to target gene mutations linked with chronic myelogenous leukemia and certain types of stomach cancers. ... CBC News,
Novartis warns Canadians about Gleevec heart risks Oct 2, 2006
Gleevec use". Gleevec, which came on to the market in 2001, targets chronic myelogenous leukemia (CML) in most patients. Studies ... Reuters
Gleevec® Approved for Pediatric CML Sep 29, 2006
Food and Drug Administration (FDA) has approved Gleevec® (imatinib mesylate) for the treatment of children with newly diagnosed chronic myelogenous leukemia. ... Cancer Consultants (press release),
Jury sides with Alpharma in arsenic, cancer lawsuit Sep 26, 2006
Greens claimed exposure to arsenic from spreading chicken litter around Prairie Grove in the 1990s caused Michael Green to develop chronic myelogenous leukemia ... Springdale Morning News,
Closing arguments set for Monday in Prairie Grove arsenic case Sep 25, 2006
Dr. Steven Lamm said there are no studies linking arsenic with chronic myelogenous leukemia, the rare type suffered by Green. He ... Pine Bluff Commercial,
Gleevec Cancer Cure Has Heart Failure Side-Effect Oct 4, 2006
...team. Also called imatinib mesylate, Gleevec is used to treat chronic myelogenous leukemia and gastrointestinal tumors. Novartis ... Market-Day.net,
No link between arsenic, litter and leukemia, jurors told Sep 20, 2006
...told jurors that, despite what experts for the other side said last week, there have been no studies to link arsenic with chronic myelogenous leukemia, or CML ... Springdale Morning News,
Doctor says leukemia rare, CML rarer Sep 14, 2006
...victims. The type cancer Green suffered, chronic myelogenous leukemia, is almost never seen in anyone under 60, Dahlgren said. "It's ... Springdale Morning News,
Cancer Drug May Be Remedy For Rheumatoid Arthritis, Study Finds Sep 30, 2006
Gleevec targets kinase gene mutations seen in chronic myelogenous leukemia or CML (a bone marrow cancer) as well as certain types of stomach cancers. ... Science Daily (press release)
Morning Trial Update: Arkansas oncologist says arsenic didn't ... Sep 22, 2006
...said he saw no evidence that either chronic or acute exposure to high levels of arsenic caused Green to develop the rare chronic myelogenous leukemia, or CML. ... Springdale Morning News,
Pounding the pavement in search of a cure Sep 10, 2006
It was tiredness and a chronic pain in her side that led Veith to her doctor in August 2003. The diagnosis: chronic myelogenous leukemia. ... Kansas City Star,
Long-term research of new cancer drugs needed Sep 16, 2006
...chemotherapy, she began taking Gleevec, a targeted drug that has proven especially effective for Reid's type of leukemia, chronic myelogenous leukemia. ... Kalamazoo Gazette,
Gleevec may halt rheumatoid arthritis Sep 28, 2006
...cells. The FDA-approved drug is currently used to treat chronic myelogenous leukemia and GIST, a form a gastrointestinal cancer. ... United Press International
Panacea to present data on cancer biomarker at research meeting Sep 12, 2006
A test to determine responsiveness to a current therapy of choice in patients with chronic myelogenous leukemia utilizing HAAH gene expression is available ... Antara,
Cancer Drug Gleevec May Ease Rheumatoid Arthritis Sep 14, 2006
It was designed to target gene mutations associated with chronic myelogenous leukemia (CLL) and certain types of stomach cancers, for which it has proven very ... Forbes
McGill, Weizmann join forces in cancer research Sep 27, 2006
Weizmann participants was Eli Canaani, whose discoveries led to the development of Gleevac, a drug now used in the treatment of chronic myelogenous leukemia. ... Canadian Jewish News,
Further Evidence that Gleevec Improves Survival of Patients with ... Sep 14, 2006
Survival benefit with imatinib mesylate versus interferon alfa based regimens in newly diagnosed chronic phase chronic myelogenous leukemia. Blood . ... Cancer Consultants (press release),
Rheumatoid Arthritis Added to Gleevec Targets -- in Mice Sep 14, 2006
The finding hints that the tyrosine kinase inhibitor - approved for the treatment of chronic myelogenous leukemia and for gastrointestinal stromal tumors ... MedPage Today,
Friends rally to help family in time of need Sep 21, 2006
Kerschner, 36, was diagnosed with chronic myelogenous leukemia (CML) about two years ago, and recently underwent a bone marrow transplant that is aimed to get ... East Brunswick Sentinel,
Gleevec for Rheumatoid Arthritis Sep 17, 2006
Doctors often prescribe Gleevec to treat people with chronic myelogenous leukemia or gastrointestinal stromal tumors, but doctors have not measured its effect ... Ivanhoe,
New blood cancer drugs show promise Sep 16, 2006
Rituxan is one of a group of new drugs that specifically targets cancer cells. Another is Gleevec, an effective treatment for chronic myelogenous leukemia. Kalamazoo Gazette,
Panacea Pharmaceuticals Launches CLIA Compliant Diagnostic Testing ... Sep 11, 2006
...expression of the gene encoding Human aspartyl (asparaginyl) Beta-hydroxylase (HAAH) in leukocytes in patients with Chronic Myelogenous Leukemia (CML) to ... Yahoo! News (press release)
"Friend Or Foe" In The Battle Against Cancer Sep 14, 2006
Rapamycin, like the pharmaceutical superstar Gleevec, which revolutionized the treatment of chronic myelogenous leukemia, is a so-called signal transduction ... Medical News Today (press release),
Statement On Cancer Genetics Findings From The NIH At Johns ... Sep 11, 2006
...said NCI Deputy Director Anna D. Barker, Ph.D. "Drugs such as Herceptin for breast cancer and Gleevec for chronic myelogenous leukemia and gastrointestinal ... Medical News Today (press release),
Connecticut girl waiting for marrow donor Nov 11, 2005
WFSB, ..."I can't ride anymore because I'm not supposed to be around animals while I have this disease." Hailey has chronic myelogenous leukemia. "It's overwhelming. ...
Koch Award Given To Pioneer Of Leukemia Research Oct 28, 2005
All Headline News Brian J. Druker the2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of ...
Leukemia Under the Microscope Nov 2, 2005
Daily Californian, The main types of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myelogenous leukemia. ...
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 6, 2005
PR Newswire (press release), ...the Registry to help save lives." In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow ...
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 6, 2005
PR Newswire (press release), In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow-growing cancer of the white blood ...
Health calendar Oct 31, 2005
Austin American-Statesman (subscription), The Leukemia and Lymphoma Society offers an education program 'Chronic Myelogenous Leukemia: Issues and Insights.' Dave and Buster's, 9333 Research Blvd. Free. ...
Cell Genesys Reports Third Quarter 2005 Financial Results Nov 2, 2005
Yahoo! News (press release) In addition, initial results from a Phase 2 trial of GVAX® vaccine for leukemia in patients with chronic myelogenous leukemia (CML) will be presented at the ...
Conference examines role of chromosome changes in cancer Oct 29, 2005
Medical News Today (press release), Later that same year, she found that something similar happened in patients with chronic myelogenous leukemia; a crucial segment of chromosome 22 broke off and ...
Phase II Study Suggests Gleevec® Is Safe and Effective for ... Oct 25, 2005
Cancer Consultants (press release), After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a ...
Robert Koch Prize and Gold Medal Awarded Oct 28, 2005
PR Newswire (press release), He receives the prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of blood cancer. ...
Gene arrangements cause most cases of prostate cancer Oct 29, 2005
Food Consumer, The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia, according to the National Cancer Institute. ...
Cell Genesys Confirms Upcoming Clinical Data Presentations for Two ... Oct 20, 2005
PR Newswire (press release), Society of Hematology (ASH) meeting in Atlanta, GA, December 12, 2005 Phase 2 Trial of GVAX(R) Leukemia Vaccine in Chronic Myelogenous Leukemia In other news ...
Fused genes trigger the development of prostate cancer Nov 1, 2005
Xagena.it, ...involved in prostate cancer, which would be analogous to Imatinib - a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia.
Group seeks bone marrow match Oct 20, 2005
Gateway Newspapers Amy was diagnosed with chronic myelogenous leukemia, a type that is rare for a child her age. The only known cure is a stem cell transplant. ...
'Amy's Army' Enlists Volunteers, Potential Donors Oct 23, 2005
KDKA, Bone Marrow Registry, although they have not yet found a match for 13-year-old Amy Katz, who was diagnosed with Chronic Myelogenous Leukemia in 2003.
NCCN Releases Updated Treatment Guidelines for Non-Small Cell Lung ... Oct 27, 2005
Business Wire (press release), Other recently updated NCCN guidelines include those for Acute Myeloid Leukemia (AML), Bone Cancer and Chronic Myelogenous Leukemia (CML). ...
American Honored For Cancer Research Oct 28, 2005
All Headline News J. Druker is awarded the 2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
As RNAi Technology Progresses Companies Try to Increase Their ... Nov 3, 2005
Genetic Engineering News, ...of RNAi are considered, in particular, the prospects of improving on existing treatment modalities for some cancers such as chronic myelogenous leukemia. ...
Gleevec® Effective for Molecular and Cytogenetic Relapses ... Oct 26, 2005
Cancer Consultants (press release), ...after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: Results of a ...
OHSU professor receives major honor in Germany Oct 28, 2005
Portland Business Journal, ...in Berlin said Friday Druker earned the honor for for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
Bristol-Myers Squibb Company Reports Financial Results for the ... Oct 28, 2005
PR Newswire (press release), Squibb plans to present Phase II data on dasatinib, a SRC/ABL Kinase Inhibitor being investigated for the treatment of chronic myelogenous leukemia (CML), at ...
New prostate cancer clue Oct 28, 2005
Newsday, The discovery that gene fusion is at the heart of chronic myelogenous leukemia, a disorder known as CML in which the body produces cancerous white blood cells ...
Researchers Use New Method to Discover Gene Rearrangements That ... Oct 27, 2005
National Institutes of Health (press release) ...the ABL gene. The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia. Epithelial tumors, such ...
Prostate cancer tied to genes Oct 28, 2005
Fort Lauderdale Sun Sentinel, If successful, it could be similar to Gleevec, which interferes with the workings of a fused gene that causes chronic myelogenous leukemia. ...
Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005
Yahoo! News (press release) ...failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced ...
SouthScape: A weekly roundup of things to do in South communities Oct 27, 2005
Pittsburgh Post Gazette, ...of Mt. Lebanon, who has chronic myelogenous leukemia, will sponsor a blood and bone marrow drive, 9 am-3 pm Nov. 6, Mt. Lebanon ...
Project Life promotes bone marrow typing Oct 21, 2005
The North Carolina State Technician, Alex Sibley, a graduate student in operations research, is a survivor because of a bone marrow transplant. "I had chronic myelogenous leukemia when I was 15. ...
Fused genes may trigger prostate cancer Oct 28, 2005
Cancerfacts.com, ...research led to the development of the leukemia pill, Gleevec®, a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia. ...
Beating the Clock Oct 15, 2005
Bremerton Sun (subscription), The first time, a pastor in Kansas City gave her some of his own bone marrow when she was battling the potentially fatal chronic myelogenous leukemia. ...
Clinical Trial Patients Spread the Word: Hope Oct 14, 2005
CancerWise Siegel was diagnosed with chronic myelogenous leukemia (CML) in April 1995 and given a 50% chance of survival with standard cancer treatments. ...
CEPHEID LAUNCHES GENEXPERT IN MOLECULAR CLINICAL RESEARCH Oct 26, 2005
Small Times The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with chronic myelogenous leukemia. ...
Cepheid Launches GeneXpert(R) System in the Molecular Clinical ... Oct 26, 2005
Yahoo! News (press release) The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with Chronic Myelogenous Leukemia (CML). ...
Hemosol Provides Corporate Update Oct 21, 2005
Canada NewsWire (press release), ...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ...
Antigenics Reports Third Quarter 2005 Financial Results and Recent ... Oct 27, 2005
Business Wire (press release), ...therapeutic cancer vaccine, in combination with Gleevec(R) (imatinib mesylate, Novartis), for the treatment of chronic myelogenous leukemia (CML) patients ...
Three new genetic mutations in brain tumors identified Oct 23, 2005
Xagena.it, ...have been implicated in several other cancers such as colorectal, breast and ovarian cancer, as well as chronic myelogenous leukemia, gastrointestinal stromal ...
Bristol-Myers Ties Revival Hopes to 3 New Drugs (Update3) 10 Sep 2005
...is seeking approval for dasatinib, which has yet to receive a brand name, for the treatment of a type of blood cancer called chronic myelogenous leukemia. ... Bloomberg
Health calendar 10 Sep 2005
Twice a month. MOMS Resource Center, 1212 N. Broadway St., Suite 150, Santa Ana. (714) 972-2610. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. ... OCRegister (subscription),
Bay Area Extra Sep 9, 2005
She is battling chronic myelogenous leukemia. Both women need marrow transplants, and the most likely match will be with a Latino donor. ... San Jose Mercury News,
Golf tournament to benefit disease research Sep 9, 2005
The golf tournament raises funds for other myeloproliferative disorders, such as polycythemia vera, chronic myelogenous leukemia and myelofibrosis. ... Bethel Beacon,
Local Medical Team Develops Effective Leukemia Treatment Aug 30, 2005
...therapy by prescribing existing leukemia medicine, such as vincristine and daunorubicin, together with Glivec, a medicine for chronic myelogenous leukemia. ... Korea Times,
Pretreated Bone Marrow Grafts Don't Lower GvHD Risk Aug 26, 2005
The diagnoses included chronic myelogenous leukemia, acute myelogenous leukemia, biphenotypic leukemia, juvenile myelomonocytic leukemia, myelodysplastic ... MedPage Today,
Leukemia treatment raises survival rate Aug 30, 2005
...imatinib from 1995 to 2001. Imatinib is the standard treatment for chronic myelogenous leukemia. According to Professor Lee's journal ... Korea Herald (subscription),
Structural GenomiX Initiates Phase 2/3 Trial of Troxatyl for the ... Aug 16, 2005
Promising early clinical results were observed in AML, myelodysplastic syndromes, blast phase chronic myelogenous leukemia, renal cell carcinoma, and ... PR Newswire (press release),
Largest Study Of Unrelated Bone Marrow Transplantation For ... Aug 15, 2005
...a higher risk of viral infection in general and higher risk of disease recurrence specifically in patients with chronic myelogenous leukemia, eliminated the ... Science Daily (press release)
Jones: I will try to keep positive Aug 22, 2005
AUBURN - When Mona Lisa Newman Jones was diagnosed with chronic myelogenous leukemia just four months back, her family rallied to help in any way that they ... Auburn Citizen,
Mother, daughter to walk in memory of family members Aug 22, 2005
Society helped finance the development of a new drug called Gleevec which can normalize white blood cells in cancer patients with chronic myelogenous leukemia. ... Muscatine Journal,
Scientists discover breast cancer pathway Aug 10, 2005
Gleevec blocks uncontrolled growth signals in Chronic Myelogenous Leukemia and Gastrointestinal Stromal Tumour, targeting c-Kit kinase, along with another ... Drug Researcher.com,
Hemosol Announces Second Quarter Financial Results Aug 12, 2005
...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ... CNW Telbec (Communiqués de presse),
Genentech Tops 2005 Pharma Achievement Awards Aug 17, 2005
For all the remarkable success of Gleevec, the Novartis drug that targets the BCR-ABL oncoprotein in chronic myelogenous leukemia, patients often develop ... Health-IT World,
Naked ladies raise funds for cancer Aug 24, 2005
Their keyboardist, Kevin Hearn, was diagnosed with chronic myelogenous leukemia, a form of blood cancer in 1998, and had to take two years off to receive ... Excalibur Online,
$9 million grant to advance work on better way to diagnose ... Jul 5, 2005
...that function,� Dr. Chan said. Such a target has been identified for chronic myelogenous leukemia (CML). A drug then was developed ... Medical News Today,
Causes, incidence, and risk factors: Jul 5, 2005
The disease has similarities to polycythemia vera, chronic myelogenous leukemia, and myelofibrosis. Usually it affects people in middle age. ... rarediseases.about.com
Health calendar Jul 3, 2005
...(714) 633-6858. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. Hoag Memorial Hospital Presbyterian, One Hoag Drive, Cancer Center, Newport Beach. ... OCRegister (subscription),
Cancer drug slows poxvirus in mice Jul 2, 2005
...are well known to cancer investigators because mutation of one family member, Abl, causes a rare form of cancer known as chronic myelogenous leukemia ( CML ). ... I-Newswire.com (press release)
Vertex and Merck Initiate Clinical Study in Hematologic Cancers ... Jun 17, 2005
...or refractory acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), acute lymphocytic leukemia (ALL) or chronic myelogenous leukemia (CML) in blast ... mysan.de (Pressemitteilung),
Claremont woman takes on marathons after surviving leukemia ... Jun 14, 2005
When she learned after a physical exam that she had chronic myelogenous leukemia her first question was, "How do you spell that?" she was told she had three to ... Inland Valley Daily Bulletin,
Vertex, Merck plan clinical study for cancer treatment Jun 17, 2005
...and tolerability of VX-680 in patients with acute myelogenous leukemia, myelodysplastic syndrome, acute lymphocytic leukemia and chronic myelogenous leukemia. ... Boston Business Journal,
A tiny piece of Geelong on the Nasdaq Jun 26, 2005
50 per cent of patients who develop a resistance to Gleevec, the most effective drug available to treat the blood cancer chronic myelogenous leukemia in its ... Australian,
Kosan's therapy may halt cancer in some patients Jun 28, 2005
...trials looking at individual cancers that showed activity in those broader studies, including multiple myeloma, breast cancer and chronic myelogenous leukemia. ... East Bay Business Times,
Kosan Initiates Phase I Clinical Trial of Second-Generation Hsp90 ... Jun 6, 2005
...and pharmacodynamics of escalating doses of KOS-1022 in patients with acute myelogenous leukemia, acute lymphocytic leukemia, or chronic myelogenous leukemia. ... PharmaLive.com (press release),
Relay participants walk to raise $115,000 Jun 11, 2005
...cause. Next year’se chairwoman, Marguerite Santorine, lost her 3-year-old daughter to juvenile chronic myelogenous leukemia. "For ... Sunbury Daily Item,
Lifebank Appoints Preeminent Hematologist to Advisory Board Jun 22, 2005
Dr. Laneuville's research interests are in the molecular biology of chronic myelogenous leukemia, genomic instability in cancer, in addition to hematopoietic ... ArriveNet (press release),
Viragen's Multiferon(R) Approved for Sale in Chile Jun 20, 2005
...recombinant alpha interferons, Multiferon® is primarily marketed for the treatment of hepatitis B, hepatitis C, chronic myelogenous leukemia, hairy cell ... Yahoo News (press release)
Viragen's Multiferon approved for sale in Chile Jun 21, 2005
...recombinant alpha interferons, Multiferon is primarily marketed for the treatment of hepatitis B, hepatitis C, chronic myelogenous leukemia, hairy cell leukemia ... Pharmaceutical Business Review
Youngster's CD benefits her musical mentor Jun 8, 2005
A little more than a year ago, Carol Harley, a member of the popular Northwest-based band Misty River, learned she had chronic myelogenous leukemia. ... Salem Statesman Journal,
Walkers hope for cancer cures Jun 17, 2005
Staples earned that honor in March of 2003, when she learned she had chronic myelogenous leukemia following a routine physical. ... MaineToday.com,
Mother-daughter duo remember a cancer victim Jun 8, 2005
...who lives in Papillion. Missman's father, Victor Hackman, was diagnosed with chronic myelogenous leukemia in 1989. He decided to ... Papillion Times,
Youngster's CD benefits her musical mentor
A little more than a year ago, Carol Harley, a member of the popular Northwest-based band Misty River, learned she had chronic myelogenous leukemia. ... Salem Statesman Journal,
Mother-daughter duo remember a cancer victim
...who lives in Papillion. Missman's father, Victor Hackman, was diagnosed with chronic myelogenous leukemia in 1989. He decided to ... Papillion Times,
Kosan Initiates Phase I Clinical Trial of Second-Generation Hsp90 ... Jun 6, 2005
...and pharmacodynamics of escalating doses of KOS-1022 in patients with acute myelogenous leukemia, acute lymphocytic leukemia, or chronic myelogenous leukemia. ... Yahoo News (press release)
Businesses gather to sponsor match for rare leukemia Jun 2, 2005
She said she was diagnosed with chronic myelogenous leukemia, a form that typically goes undetected by doctors until it's too late for treatment. ... Harlem Valley Times,
ON THE ISLE Jun 5, 2005
...and cancer at 23.". In 2001, with everything else in her life going gang-busters, Zammett was diagnosed with chronic myelogenous leukemia. ... Newsday,
Testing 'smart drugs' on children with cancer May 31, 2005
And Gleevec, which first won approval in adults with gastrointestinal stromal tumors and chronic myelogenous leukemia, two diseases that are rarer in children ... Pittsburgh Post Gazette,
WHS student overcomes obstacles to success Jun 3, 2005
By Jenica schultz. His father, Chuck Wilson, was diagnosed with Chronic Myelogenous Leukemia, and nearly didn't make it. Between ... The Post & Mail,
Longer Treatment Durations and the Launch of Novel Treatments Will ... May 19, 2005
...care issues, finds that longer treatment durations and the launch of novel treatments will grow the drug market for chronic myelogenous leukemia almost 12 ... PR Newswire (press release)
Trio Of Leukemias Share A Single Mutation May 31, 2005
...these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which ... Science Daily (press release)
Kosan Presents Data on KOS-953 From Single-Agent and Combination ... Jun 3, 2005
FDA) and the European Medicines Agency (EMEA) for the treatment of multiple myeloma as well as another hematologic cancer, chronic myelogenous leukemia. ... PharmaLive.com (press release),
Florida Family Says Boise Mayor Saved Their Lives Jun 2, 2005
Chiucchi, diagnosed with chronic myelogenous leukemia in 2000, says without the gift of Bieter's bone marrow in 2003, he'd be a dead man. ... KBCI,
Barrington bone marrow drive nets 102 donors, raises $13,000 May 23, 2005
...own, to educate area residents and locate potential donors for 3-year-old Hristianna Lanoue of Spofford, who was diagnosed with chronic myelogenous leukemia. ... Foster's Daily Democrat,
Two Top Stem Cell Researchers Moving West to Stanford; The ... May 23, 2005
Institute for Cancer/Stem Cell Biology and Medicine, isolated and characterized cancer stem cells that lead to the acute phase of chronic myelogenous leukemia. ... PharmaLive.com (press release),
Protein Mutations May Predict Outcomes for GIST Patients Treated ... May 23, 2005
...of cells. Gleevec is a drug that is currently approved for the treatment of chronic myelogenous leukemia and GIST. The function ... Cancer Consultants (press release),
Drug Used for Symptoms Attacks Disease Too May 15, 2005
Farber Cancer Center in Boston compared it with what doctors saw in early tests of the drug Gleevec on people with chronic myelogenous leukemia several years ... Newsday,
DRUG MAKERS AIM FOR A BULL'S-EYE May 13, 2005
...studying something for rheumatoid arthritis and found out it also targets the very special enzyme that is a genetic defect in chronic myelogenous leukemia, CML ... Newark Star Ledger,
Elizabeth Blackburn and Janet Rowley Awarded 2005 Landon-AACR ... 17 Mar 2005
Later that same year, she discovered that another defect linked to chronic myelogenous leukemia (CML), known as the Philadelphia chromosome, also resulted from ... Medical News Today
Bone-marrow transplant is senior's top challenge 17 Mar 2005
Tennessen learned Sept. 4 he had Chronic Myelogenous Leukemia (CML), a cancer of the blood that causes white blood cells to produce at an alarmingly high rate. ... Sioux Falls Argus Leader
New drug for chronic myelogenous leukemia: Feb 14, 2005
...[Health India]: BOSTON, Feb. 14 : Researchers in Boston and Switzerland have created a targeted therapy for chronic myelogenous leukemia, or CML. ... New Kerala
NCCN Releases Acute Myeloid Leukemia and Chronic Myelogenous ... Feb 28, 2005
Network (NCCN) announces the release of Chapters 4 and 5 of the NCCN Drugs & Biologics Compendium(TM): Acute Myeloid Leukemia and Chronic Myelogenous Leukemia. ... Business Wire
Designer drug potent treatment for chronic myelogenous leukemia Feb 16, 2005
...laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a newly designed targeted therapy for chronic myelogenous leukemia (CML) may ... ScienceBlog.com
Designer Drug Is Potent Treatment for Chronic Myelogenous Leukemia Feb 18, 2005
...study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ... Newswise
Myelodysplastic and Myeloproliferative Disorders of Childhood Mar 14, 2005
...[2]. The MPS disease most commonly seen in children is the adult form of chronic myelogenous leukemia (CML) (t[9:22] or BCR/ABL containing CML). ... Medscape (subscription)
Cancer Drug for Diabetes? Mar 14, 2005
Gleevec was designed to disable a defect in a protein called a tyrosine kinase that occurs in chronic myelogenous leukemia (CML), a blood cancer. ... Science Magazine (subscription)
Protein Design Labs Announces Above Consensus Full-Year and Fourth ... Mar 14, 2005
...combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia. ... Yahoo News
Temple is more than Chaney and Cosby Mar 15, 2005
Temple researchers developed a drug that could treat all forms of chronic myelogenous leukemia, which is a rare but deadly form of cancer, according to the ... Temple News Online (subscription)
Plant Derivative Attacks The Roots Of Leukemia Mar 2, 2005
...how a concentrated form of parthenolide would act on the most primitive types of acute myelogenous leukemia cells, chronic myelogenous leukemia cells and ... Science Daily
Improved leukemia drug packs more potent punch Feb 14, 2005
By Jessica Heslam. Hub researchers have helped to develop a better drug to treat people with chronic myelogenous leukemia. The drug ... Boston Herald
Plant Derivative Kills Leukemia Cells Mar 1, 2005
The chemical showed strong apoptotic activity against primary human AML cells as well as blast crisis chronic myelogenous leukemia (CML) cells. ... Cancerpage.com
Firefighter's climb a tribute to a cure Mar 4, 2005
After several visits to doctors and emergency rooms, Jacobson was diagnosed with chronic myelogenous leukemia. "Part of me was kind of expecting it. ... Everett Herald
Residents gear up to walk for a cure in Relay Mar 10, 2005
Cleaver was diagnosed with chronic myelogenous leukemia in 1996, but was cured by an excruciating round of bone marrow transplants. ... Acton-The Beacon
CHS senior battling leukemia Feb 24, 2005
Palous. Said Randle: "It's just nice to know I have a lot of support.". Randle has chronic myelogenous leukemia (CML). The diagnosis ... Ceres Courier
Ex-Bruins players to play at leukemia fundraiser Feb 14, 2005
It began in 1994 as the brainchild of city resident and figure skater Laura Dully whose husband was diagnosed with chronic myelogenous leukemia two years ... MetroWest Daily News
Study finds new designer drug is potent treatment for chronic ... Feb 14, 2005
...at Dana-Farber Cancer Institute and Novartis Pharmaceuticals in Basel, Switzerland have created a targeted therapy for chronic myelogenous leukemia (CML) that ... EurekAlert
The fight against cancer lives on: Feb 24, 2005
Kevin was diagnosed in 1992 with chronic myelogenous leukemia. He has been in remission since 1994 -- the year Laura began Lace Up for Leukemia. ... MetroWest Daily News
Heart Transplant in a Young Man With Schizophrenia Mar 1, 2005
The first was a 44-year-old man diagnosed with chronic schizophrenia who received a bone marrow transplant for chronic myelogenous leukemia. ... Am J Psychiatry (subscription)
Antigenics Reports Fourth Quarter and Year-End 2004 Financial ... Feb 24, 2005
...trial of AG-858, a personalized therapeutic cancer vaccine, in combination with Gleevec(R) (Novartis) for the treatment of chronic myelogenous leukemia is on ... Business Wire
Researchers Create New Drug for Leukemia Feb 12, 2005
US and Swiss researchers have designed a new drug to treat chronic myelogenous leukemia that ultimately could be more effective than the current treatment. ... RedNova.com
Novartis’ Alternative to Gleevec Tested in Mice 2/16/05 Feb 16, 2005
Basel, Switzerland, and Dana-Farber Cancer Institute, Boston, released a new report on AMN107, a targeted therapy for chronic myelogenous leukemia (CML) that ... Genomics & Proteomics (subscription)
Chronic Myelogenous Leukemia Archive
Chronic myelogenous leukemia (or CML) is a form of chronic leukemia characterised by increased production of myeloid cells in the bone marrow. The overwhelming majority is due to a characteristic chromosomal translocation termed the Philadelphia chromosome. It is traditionally treated with chemotherapy, interferon and bone marrow transplantation, although a specific inhibitor (imatinib mesylate) has radically changed the management.
|
|
|
